Top
Bluestem
  • Who We Are
  • Strategy
  • Portfolio
  • Newsroom
  • INVESTOR PORTAL
Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL/
iStock-645678506 dark.png
Bluestem

Newsroom

Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL/

News From the Bluestem Team


July 22, 2026

The FDA Vote That Could Redefine How We Treat Eyes

July 22, 2026/ Nikole Mulder

Click here to read an article published in The Myopia Mindset by Cary Herzberg regarding how a single low-dose atropine ruling could turn optometry into the preventative-care profession it was always meant to be.

To access a PDF of the story click here.

Shared by Tyler Stowater, board member of Sydnexis, Inc.

July 22, 2026/ Nikole Mulder/

Nikole Mulder

  • Sydnexis in the News
  • Sydnexis Announces FDA Advisory ...

*Legal Disclaimer: NEWSROOM The content provided herein is for informational and convenience purposes only. The information provided on this website does not constitute an offer to buy or sell any securities or provide any form of investment advice.  Bluestem Capital Company, LLC assumes no responsibility nor makes any claims as to the quality, accuracy or usefulness of third-party linked content made available on this site.

Bluestem is the registered service mark of Bluestem Capital Company, LLC. All Rights Reserved.